Despite the global burden of HIV-1, the majority of sequence data and research remain disproportionately focused on subtype B, primarily circulating in the global north. Sub-Saharan Africa, the ...
Cyclin-dependent kinase 4/6 (CDK4/6) inhibitor SHR6390 combined with pyrotinib and letrozole in patients with human epidermal growth factor receptor 2-positive (HER2+), hormone receptor positive (HR+) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results